Biomarkers in Samples From Young Patients With Neuroblastoma
Completed
- Conditions
- Neuroblastoma
- First Posted Date
- 2011-05-23
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01358604
Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma
Completed
- Conditions
- Disseminated NeuroblastomaRecurrent NeuroblastomaLocalized Unresectable NeuroblastomaStage 4S NeuroblastomaLocalized Resectable Neuroblastoma
- Interventions
- Other: diagnostic laboratory biomarker analysis
- First Posted Date
- 2011-05-23
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 90
- Registration Number
- NCT01358617
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Completed
- Conditions
- NeuroblastomaPleuropulmonary BlastomaSarcomaLiver CancerHereditary Wilms TumorKidney CancerBrain and Central Nervous System Tumors
- First Posted Date
- 2011-05-13
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 31
- Registration Number
- NCT01353300
Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma
Completed
- Conditions
- Sarcoma
- First Posted Date
- 2011-04-27
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01342783
Biomarkers in Tissue Samples From Young Patients With Liver Cancer
Completed
- Conditions
- Childhood HepatoblastomaStage I Childhood Liver CancerStage III Childhood Liver CancerStage IV Childhood Liver CancerStage II Childhood Liver Cancer
- Interventions
- Genetic: RNA analysisGenetic: gene expression analysisGenetic: microarray analysisGenetic: nucleic acid sequencingOther: diagnostic laboratory biomarker analysis
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 99
- Registration Number
- NCT01336881
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
Phase 2
Completed
- Conditions
- Recurrent Neuroblastoma
- Interventions
- Biological: hu14.18-IL2 fusion proteinBiological: sargramostimOther: laboratory biomarker analysis
- First Posted Date
- 2011-04-13
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 52
- Registration Number
- NCT01334515
- Locations
- πΊπΈ
University of Alabama at Birmingham, Birmingham, Alabama, United States
πΊπΈUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
πΊπΈChildren's Oncology Group, Arcadia, California, United States
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 97
- Registration Number
- NCT01321385
Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor
Completed
- Conditions
- Renal FailureKidney Cancer
- First Posted Date
- 2011-03-14
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01314391
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
Phase 3
Completed
- Conditions
- Acute Myeloid LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With MaturationAdult Acute Myeloid Leukemia With Minimal DifferentiationAdult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
- Interventions
- First Posted Date
- 2011-03-03
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 517
- Registration Number
- NCT01307579
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Phase 3
Completed
- Conditions
- Chronic Eosinophilic LeukemiaChronic Neutrophilic LeukemiaDisseminated NeuroblastomaPreviously Treated Myelodysplastic SyndromesRecurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood RhabdomyosarcomaRecurrent Malignant Testicular Germ Cell TumorRecurrent/Refractory Childhood Hodgkin LymphomaUnspecified Childhood Solid Tumor, Protocol SpecificChildhood Acute Lymphoblastic Leukemia in Remission
- Interventions
- Other: placeboDrug: supersaturated calcium phosphate rinseOther: questionnaire administrationProcedure: quality-of-life assessment
- First Posted Date
- 2011-02-28
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 226
- Registration Number
- NCT01305200
- Locations
- πΊπΈ
Children's Oncology Group, Arcadia, California, United States
πΊπΈCity of Hope, Duarte, California, United States
πΊπΈChildren's Hospital and Research Center at Oakland, Oakland, California, United States